119 related articles for article (PubMed ID: 10671663)
1. pS2 expression as a possible diagnostic marker of colorectal carcinoma in ulcerative colitis.
Hirota Y; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Oncol Rep; 2000; 7(2):233-9. PubMed ID: 10671663
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
Fujii S; Fujimori T; Chiba T
J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
[TBL] [Abstract][Full Text] [Related]
3. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.
Chaubert P; Benhattar J; Saraga E; Costa J
Am J Pathol; 1994 Apr; 144(4):767-75. PubMed ID: 8160776
[TBL] [Abstract][Full Text] [Related]
4. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma.
Sato A; MacHinami R
Pathol Int; 1999 Oct; 49(10):858-68. PubMed ID: 10571818
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of DNA methyltransferase-1 in non-neoplastic epithelium helps predict colorectal neoplasia risk in ulcerative colitis.
Fujii S; Katake Y; Tanaka H
Digestion; 2010; 82(3):179-86. PubMed ID: 20588031
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
Brüwer M; Schmid KW; Senninger N; Schürmann G
World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.
Chen R; Pan S; Lai K; Lai LA; Crispin DA; Bronner MP; Brentnall TA
World J Gastroenterol; 2014 Dec; 20(45):17037-48. PubMed ID: 25493016
[TBL] [Abstract][Full Text] [Related]
8. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical distribution of p53 and Ki-67 in 2 cases of colorectal carcinoma occurring in ulcerative colitis].
Maruyama K; Saigusa N; Baba S; Kino I
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():145-8. PubMed ID: 7611778
[TBL] [Abstract][Full Text] [Related]
10. Mutations of p53 in morphologically non-neoplastic mucosa of long-standing ulcerative colitis.
Takaku H; Ajioka Y; Watanabe H; Hashidate H; Yamada S; Yokoyama J; Kazama S; Suda T; Hatakeyama K
Jpn J Cancer Res; 2001 Feb; 92(2):119-26. PubMed ID: 11223540
[TBL] [Abstract][Full Text] [Related]
11. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
[TBL] [Abstract][Full Text] [Related]
12. Expression Profile of p53 and p21 in Large Bowel Mucosa as Biomarkers of Inflammatory-Related Carcinogenesis in Ulcerative Colitis.
Popp C; Nichita L; Voiosu T; Bastian A; Cioplea M; Micu G; Pop G; Sticlaru L; Bengus A; Voiosu A; Mateescu RB
Dis Markers; 2016; 2016():3625279. PubMed ID: 27578918
[TBL] [Abstract][Full Text] [Related]
13. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
AbdElazeem MA; El-Sayed M
Ann Diagn Pathol; 2015 Dec; 19(6):369-74. PubMed ID: 26420348
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the Changes in Mitochondrial Gene Polymorphism in Ulcerative Colitis and the Etiology of Ulcerative Colitis-associated Colorectal Cancer.
Tanaka T; Kobunai T; Yamamoto Y; Murono K; Emoto S; Hiyoshi M; Kaneko M; Sasaki K; Shuno Y; Nishikawa T; Hata K; Kawai K; Nozawa H; Ishihara S
Anticancer Res; 2020 Jan; 40(1):101-107. PubMed ID: 31892558
[TBL] [Abstract][Full Text] [Related]
15. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma.
Harpaz N; Peck AL; Yin J; Fiel I; Hontanosas M; Tong TR; Laurin JN; Abraham JM; Greenwald BD; Meltzer SJ
Hum Pathol; 1994 Oct; 25(10):1069-74. PubMed ID: 7927312
[TBL] [Abstract][Full Text] [Related]
16. Midkine expression in colorectal tumors: correlation with Ki-67 labeling in sporadic, but not ulcerative colitis-associated ones.
Tokuyama W; Mikami T; Fujiwara M; Matsui T; Okayasu I
Pathol Int; 2007 May; 57(5):260-7. PubMed ID: 17493173
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis.
Sato F; Harpaz N; Shibata D; Xu Y; Yin J; Mori Y; Zou TT; Wang S; Desai K; Leytin A; Selaru FM; Abraham JM; Meltzer SJ
Cancer Res; 2002 Feb; 62(4):1148-51. PubMed ID: 11861396
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of chromogranin A and p53 expressions in ulcerative colitis-associated neoplasia: neuroendocrine differentiation as an early event in the colitis-neoplasia sequence.
Shigaki K; Mitomi H; Fujimori T; Ichikawa K; Tomita S; Imura J; Fujii S; Itabashi M; Kameoka S; Sahara R; Takenoshita S
Hum Pathol; 2013 Nov; 44(11):2393-9. PubMed ID: 24029705
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein: early marker in the carcinogenesis of ulcerative colitis-associated colorectal carcinoma.
Bruewer M; Schmid KW; Krieglstein CF; Senninger N; Schuermann G
World J Surg; 2002 Jun; 26(6):726-31. PubMed ID: 12053227
[TBL] [Abstract][Full Text] [Related]
20. Cytoglobin expression of rectal subepithelial myofibroblasts: significant alterations of cytoglobin+ stromal cells in long-standing ulcerative colitis.
Okayasu I; Mikami T; Yoshida T; Hana K; Yokozawa M; Sada M; Fujiwara M; Kawada N
Histol Histopathol; 2011 Jun; 26(6):679-88. PubMed ID: 21472683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
